GLP-1 Receptor Stabilizers for Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in maintaining the monodispersity and stability of the glucagon-like peptide 1 (GLP-1) receptor during purification and crystallization processes, which are crucial for structural determination and drug development.
Innovation Solution
Development of specific compounds that act as stabilizers or modulators of the GLP-1 receptor, enabling its stabilization and facilitating structural analysis by maintaining the receptor in a monodisperse, functional state, thereby supporting high-resolution structural determination and drug development.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If conventional purification and crystallization methods are used for GLP-1 receptor, then the structural determination process can proceed, but the receptor loses its monodispersity and stability during the process
Solution Approach 1:
The patent introduces small molecule compounds as intermediary stabilizers that bind to the GLP-1 receptor and maintain its functional conformation. These compounds act as mediators between the receptor and the purification/crystallization process, preventing aggregation and degradation while enabling successful structural determination.
Solution Approach 2:
The patent employs compounds that induce parameter changes in the receptor's physical and chemical properties, particularly enhancing thermal stability and maintaining monodispersity. These parameter changes allow the receptor to withstand the demanding conditions of purification and crystallization while remaining functional.
2Measurement precision
If the GLP-1 receptor is stabilized for crystallization, then high-resolution structural determination becomes possible, but requires specific stabilizing compounds that must be developed and screened
Solution Approach 1:
The patent applies preliminary stabilization action by treating the GLP-1 receptor with small molecule compounds before purification and crystallization. This preliminary stabilization ensures the receptor maintains its functional state throughout the subsequent processing steps, enabling high-resolution structural determination without requiring complex in-process adjustments.
3Reliability
If the GLP-1 receptor is maintained in a functional state during purification, then structural analysis can be performed, but the receptor is prone to aggregation and degradation
Solution Approach 1:
Small molecule compounds serve as intermediary stabilizers that bind to the GLP-1 receptor and protect it from aggregation and degradation. These mediators maintain the receptor's functional conformation while providing physical and chemical stability during purification and storage.
Solution Approach 2:
The patent creates a composite system consisting of the GLP-1 receptor complexed with small molecule stabilizers. This composite structure combines the functional properties of the receptor with the stabilizing properties of the small molecules, resulting in a more robust preparation that resists aggregation and degradation.
Data Source
AI summary
Compounds that bind the glucagon-like peptide 1 receptor (GLP-1) receptor are provided including compounds which are modulators of the GLP-1 receptors and compounds which are capable of inducing a stabilizing effect on the receptor for use in structural analysis of the GLP-1 receptor. Methods of synthesis, methods of therapeutic and/or prophylactic use, and methods of use in stabilizing GLP-1 receptor in vitro for crystallization of the GLP-1 receptor of such compounds are provided.